This article is a correction to:
CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder
Cataldo Martucci
Andrew Dennis AllenNadia MorettoValentina BagnacaniAlessandro Fioni
Riccardo PatacchiniMaurizio Civelli
Gino Villetti
Fabrizio Facchinetti*- Corporate Pre-Clinical R&D, Chiesi Farmaceutici S.p.A., Parma, Italy
by Martucci C, Allen AD, Moretto N, Bagnacani V, Fioni A, Patacchini R, Civelli M, Villetti G and Facchinetti F (2024). Front. Pharmacol. 15:1343941. doi: 10.3389/fphar.2024.1343941
In the published article, there was an error in Figure 1 as published. The chemical structures described in Figure 1 were inaccurate. The corrected Figure 1 and its caption appear below.
Figure 1
Figure 1. Chemical structures of the p38α inhibitors CHF6297, losmapimod, and AZD7624.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: inflammation, P38 alpha, chronic obstructive pulmonary disease, cytokines, neutrophilia
Citation: Martucci C, Allen AD, Moretto N, Bagnacani V, Fioni A, Patacchini R, Civelli M, Villetti G and Facchinetti F (2024) Corrigendum: CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder. Front. Pharmacol. 15:1497520. doi: 10.3389/fphar.2024.1497520
Received: 17 September 2024; Accepted: 30 September 2024;
Published: 25 October 2024.
Edited and reviewed by:
Julie Gunnells Ledford, University of Arizona, United StatesCopyright © 2024 Martucci, Allen, Moretto, Bagnacani, Fioni, Patacchini, Civelli, Villetti and Facchinetti. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Fabrizio Facchinetti, f.facchinetti@chiesi.com